Company Quick10K Filing
Immune Pharmaceuticals
S-1 2018-11-21 Public Filing
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-06-14
10-K 2016-12-31 Filed 2017-05-17
10-Q 2016-09-30 Filed 2016-11-18
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-17
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-04-09
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-02
10-Q 2013-03-31 Filed 2013-05-20
10-K 2012-12-31 Filed 2013-03-05
10-Q 2012-06-30 Filed 2012-08-10
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-10
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-10
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-09
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-03-15
8-K 2019-02-17
8-K 2019-02-08
8-K 2018-12-19
8-K 2018-12-05
8-K 2018-11-26
8-K 2018-11-23
8-K 2018-10-18
8-K 2018-10-09
8-K 2018-09-12
8-K 2018-09-10
8-K 2018-08-28
8-K 2018-07-24
8-K 2018-06-04
8-K 2018-05-14
8-K 2018-05-01
8-K 2018-02-23
8-K 2018-02-15
8-K 2018-02-12
8-K 2018-02-07
8-K 2018-01-25
8-K 2018-01-09

Immune Pharmaceuticals Financials

IMNP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Nuo Therapeutics (AURX) 3,796 69% -2.2 -1,173% 154 1,347 344 236 -1,810 -1,734 3,787
Wize Pharma (WIZP) 3,714 0% -0.9 -123% 2,091 2,238 2 0 -2,577 -2,577 2,229
Encision (ECIA) 3,709 51% -115.6 -4% 4,148 1,933 8,055 4,147 -152 -31 3,568
Geospatial (GSPH) 3,709 70% -6.3 -736% 111 3,656 273 190 -816 -586 3,668
Mentor Capital (MNTR) 3,702 29% -1.0 -59% 5,269 1,972 3,177 930 -3,131 -3,080 2,951
Blake Insomnia Therapeutics (BKIT) 3,681 -135.2 0 237 0 0 -27 -27 3,681
Cartesian (CRTN) 3,632 30% -0.4 -44% 16,522 17,461 47,555 14,053 -7,270 -5,582 2,087
Invesco CurrencyShares Singapore Dollar Trust (FXSG) 3,628 0% -50.4 1% 3,558 1 40 0 26 26 -1,288
Fieldpoint Petroleum (FPP) 3,628 0% 13.8 -5% 4,528 6,259 1,668 0 -241 247 3,414
Immune Pharmaceuticals (IMNP) 3,597 -0.9 -71% 20,716 19,874 0 0 -14,715 -13,953 12,494
American Bio Medica (ABMC) 3,580 35% -28.9 -20% 2,246 2,809 2,776 971 -440 -177 5,119
Empire Petroleum (EMPR) 3,576 0% -3.0 -30% 11,795 13,670 4,941 0 -3,541 -3,815 11,553
Genesis Financial (GFNL) 3,571 0% -1.1 -155% 2,427 3,394 10 0 -3,756 -3,242 3,551
Frontier Oilfield Services (FOSI) 3,542 0% -5.7 -319% 868 11,161 646 0 -2,768 -2,021 11,479
Coretec (CRTG) 3,505 -2.8 -107% 1,424 3,504 0 0 -1,520 -1,229 3,497
Sauer Energy (SENY) 3,496 49% -2.8 -116% 1,092 291 30 15 -1,271 -1,239 3,494
Vycor Medical (VYCO) 3,465 91% -6.4 -53% 1,086 2,353 1,127 1,020 -575 -530 3,367
Puradyn Filter Technologies (PFTI) 3,451 24% -14.2 -47% 2,470 12,620 1,278 303 -1,160 -826 11,763
Igen Networks (IGEN) 3,418 68% -2.6 -137% 604 2,437 594 405 -830 -1,315 3,381
Invesco CurrencyShares Chinese Renminbi Trust (FXCH) 3,414 0% 1,654.7 -0% 3,419 1 4 0 -13 -13 -21,003

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash14,57810,6166,3785,0814,7731,131800700600417496,5143,1799346,7674,0181,3978,9564,5431,08740631727111122766,7762,7341,508100
Accounts Receivable
Inventory166205576766
PP&E1621391201021,7641,7651,3421,3421,34271734749479262605644835534433548132658580316197
Assets16,84712,1917,5216,1625,3022,8661,3281,25796032,07831,50137,95334,47132,17737,86435,29532,57440,25636,18432,60831,87331,55419,10518,88422,39622,31028,60824,32722,26220,716
Accounts Payable1,6271,0521,1231,0668329451,3491,7402,3045,0945,1814,0843,2922,6861,2431,9572,9841,2482,4392,8863,6023,5013,5223,7364,5076,6143,5693,6833,5975,535
Long-Term Debt6,1415,386003764,9055,1784,6014,1033,5753,0932,6073,6624,8874,9004,5004,1004,7093,22610,5957,7755,3875,3878,8938,997
Liabilities26,57226,44524,66723,30317,85916,03415,29715,86817,14124,25326,01832,33727,78021,25620,32019,87419,05625,60926,66226,62425,58019,88616,59215,12422,52721,73714,85014,97217,60519,874
Stockholders' Equity-9,725-14,254-17,146-17,141-12,557-13,168-13,969-14,611-16,1817,8255,4832,5206,69110,92117,54415,42113,51812,5657,8634,4395,19011,6682,5133,760-13157313,7589,3554,657842
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue22427542416,602871037699190200000000000000000
Cost of Revenue
Gross Profit
R&D1,9912,6171,5611,2969631,104373306811,0071,0513389862,6901,6261,1501,1261,1272,5312,0111,9452,3382,0391,0281,4171,2291,8432,3942,8802,054
SG&A2,0421,9771,0391,4301,3848529408109271,0082,2112,5413,5683,7182,4312,3031,6822,2273,5782,4139231,6461,4451,6671,3671,6101,9621,9321,4501,644
Tax20200-45038000000810-4,93700000
Net Income-4,342-3,5282,959-1,132-872-1,100-1,6841,598-3,444-4,779260-11,941-7,090-3,556-2,876-4,160-6,565-5,132-3,656-12,249-11,624-3,7533,560-6,051-3,149-4,384-3,050-4,132
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-3,917-3,069-1,590-1,150-454-948-1,424-1,042-3,369-3,093-4,049-3,353-2,248-2,174-5,435-4,049-3,447-3,421-2,893-1,560-764-6,342-3,692-3,157-1,495
Cash Investing-14268138-2046892-46-21-13-97-17-5012250-6-31-30-38
Cash Financing-3161,781-778-943-734107283,2805369,854-2881,7159,184-455-42613,007-26781,8343,3822,8612,7211,44613,048-3191,961101